Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Homotaurine (3-Aminopropanesulfonic Acid).
Homotaurine is a synthetic small-molecule analog of taurine that acts as a GABAergic agonist and an anti-amyloidogenic agent, primarily utilized for its neuroprotective potential in mitigating cognitive decline and amyloid-beta aggregation.
10476
105.92 g/mol
1.1
carbononitridic bromide
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Homotaurine (3-Aminopropanesulfonic Acid) across standard consumer modalities.
Homotaurine is highly hygroscopic, requiring moisture-resistant HPMC capsules and desiccants to prevent clumping and maintain chemical stability.
The acidic nature of homotaurine can interfere with pectin gelation, necessitating precise pH buffering to ensure structural integrity and prevent syneresis.
The high effective dosage requirements of homotaurine often exceed the typical 50mg payload capacity of thin-film matrices, complicating formulation for therapeutic efficacy.
Ready to launch a product featuring Homotaurine (3-Aminopropanesulfonic Acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Homotaurine (3-Aminopropanesulfonic Acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Homotaurine (3-Aminopropanesulfonic Acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation